Trial in Progress: CAR-T (idecabtagene vicleucel) in ADvanced Myeloma plus Iberdomide or Usual Monitoring (The A062102 CADMIUM Study)
Google Scholar   
Citation:
Meeting Instance:
ASH 2025
Year:
2025
Type:
Abstract
Sub type:
Funding:
NCTN
Endpoint:
No-Endpoint
Analysis:
Trial-Description-Only
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
Note:
Methodological:
No
Biospecimen:
No
SDC:
No
Parents:
None
Children:
None
Program:
OGC
Primary Committee:
Myeloma
Sec. Committees:
   
Pharmas:
BMS  
Grants:
U10CA180821, U10CA180882; U10CA180868 (NRG Oncology)  
Corr. Author:
 
Authors:
                                       
Networks:
GREENVILLE, IWORC, LAPS-MA036, LAPS-MN026, LAPS-NC007, LAPS-NY016, LAPS-NY158, LAPS-TX011, NC002, NE003, PA121, PCRC, TX036   
Study
Alliance-A062102
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
2
Keywords: